Thursday Nov 5 | Medical News Today
Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In...
Main Category: Alzheimer's / Dementia Also Included In: Clinical Trials / Drug Trials Article Date: 04 Nov 2009 - 23:00 PST Pfizer Inc and Medivation, Inc.
Smart Pills: More Focus or Hocus Pocus?
Theya TMre all the buzz, and more of my patients seem to be asking for them: Drugs that can improve attention span and memory and help them be more productive at work.
EPIX Pharmaceuticals Announces FDA Approval Of A Physician-Sponsored...
Main Category: Alzheimer's / Dementia Also Included In: Pharma Industry / Biotech Industry Clinical Trials / Drug Trials The FDA has approved a Physician-Sponsored IND and continuation of the fourth 6-month open label extension of PRX-03140, a novel 5HT4 partial agonist for the potential treatment of Alzheimer's Disease.
Smartness In A Bottle: Nootropics Reach Concern Levels In Students
A Some estimates in competitive sports put athletic doping usage at 95%, for example, which sounds ridiculously high unless your slippery slope meter works overtime.
Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimer's
People taking one of several drugs commonly prescribed to treat Alzheimer's disease are more likely to be hospitalized for a potentially serious condition called bradycardia than patients not taking these medications.
Increase in 'academic doping' could spark routine urine tests for exam students
The increasing use of smart drugs or "nootropics," to boost academic performance, could mean that exam students will face routine doping tests in future, suggests an article in the Journal of Medical Ethics .
Eisai Announces Agreement with Pfizer on Strategic Alliance for...
Eisai Co., Ltd. announced that it has reached a comprehensive agreement with Pfizer Inc.
Aricept Opens Doors To Dreaming
Every medication can have side effects. That's a given. Whether or not you can live with the side effect is the big question.
Where can I get more informatin?. If you take viagra soft tabs, celecoixb for a long period of time, your doctor cymbalta withdrawal, may want to check you on a regular basis buy clonazepam without prescription, to make sure this medicaton is not causng harmul lawsuits for reglan, effecst.
SHRI enrolls Alzheimera s patients in clinical trial
Sun Health Research Institute is enrolling patients with Alzheimer's disease in the CONCERT study, a new clinical trial that will test an investigational drug.
Drugs to treat dementia wanted on NHF list
The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies.
Drugs to treat dementia wanted on NHF list
The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies.
Drugs to treat dementia wanted on NHF list
The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies.
Drugs to treat dementia wanted on NHF list
The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies.
Drugs to treat dementia wanted on NHF list
The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies.
Medivation Reports Second Quarter 2009 Financial Results and Provides Corporate Update
Medivation, Inc. today reported on its corporate progress and financial results for the second quarter ended June 30, 2009.
At a certain hour of the night, the television airwaves are back-to-back-to-back with pharmaceutical advertisements directed at baby boomers.
Alzheimer's drugs slow progression of disease
Medication can improve the quality of life for people with Alzheimer's and their caregivers.
Financial Relief to Those with Alzheimera s
Monday, 27 July 2009, 1:24 pm Press Release: Mylan New Zealand Mylan New Zealand today announced that the first generic prescription medicine for those with Alzheimer's disease, the most common cause of dementia, is now available in New Zealand.
Neuropsychology Abstract of the Day: Alzheimer Drug Regimens & Delivery Systems
Bassil, N & Grossberg, GT. . Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease.
Also on Topix